AKT1 and osteosarcoma: Kita et al. (2017) reported that nitidine chloride inhibits cell migration and invasion through the Akt/GSK-3β/Snail signaling pathway, highlighting the potential of repurposing existing drugs to target EMT in osteosarcoma [29].